4.3 Editorial Material

siRNA nanomedicine: the promise of bioreducible materials

期刊

EXPERT REVIEW OF MEDICAL DEVICES
卷 10, 期 1, 页码 7-10

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1586/ERD.12.73

关键词

controlled release; degradable polymer; gene delivery; nanodevice; nanoparticle; siRNA

资金

  1. NCI NIH HHS [R21CA152473, R21 CA152473] Funding Source: Medline
  2. NATIONAL CANCER INSTITUTE [R21CA152473] Funding Source: NIH RePORTER

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Nanoscience & Nanotechnology

Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma

Kelly R. Rhodes, Ariel Isser, John W. Hickey, Elana Ben-Akiva, Randall A. Meyer, Alyssa K. Kosmides, Natalie K. Livingston, Stephany Y. Tzeng, Jonathan P. Schneck, Jordan J. Green

Summary: Biomimetic biomaterials show promise in cancer immunotherapy by engaging the immune system to generate antitumor responses. By modulating the interface between biomaterial surfaces and target cells, enhanced biological functions can be achieved. Synthetic artificial antigen presenting cells have potential as a directly injectable acellular therapy in the future.

ACS APPLIED MATERIALS & INTERFACES (2021)

Article Chemistry, Multidisciplinary

Photocrosslinked Bioreducible Polymeric Nanoparticles for Enhanced Systemic siRNA Delivery as Cancer Therapy

Johan Karlsson, Stephany Y. Tzeng, Shayan Hemmati, Kathryn M. Luly, Olivia Choi, Yuan Rui, David R. Wilson, Kristen L. Kozielski, Alfredo Quinones-Hinojosa, Jordan J. Green

Summary: This study introduces a novel strategy involving photocrosslinking of bioreducible nanoparticles to enhance the systemic delivery of RNA. The photocrosslinked bioreducible nanoparticles exhibit improved stability and efficient siRNA-mediated gene silencing effects in melanoma tumors, providing potential for advancing nucleic acid-based therapeutics delivery technologies.

ADVANCED FUNCTIONAL MATERIALS (2021)

Article Oncology

Poly(beta-amino ester) nanoparticles enable tumor-specific TRAIL secretion and a bystander effect to treat liver cancer

Hannah J. Vaughan, Camila G. Zamboni, Nicholas P. Radant, Pranshu Bhardwaj, Esther Revai Lechtich, Laboni F. Hassan, Khalid Shah, Jordan J. Green

Summary: Researchers have developed poly(beta-amino ester) nanoparticles to locally deliver a secretable TRAIL protein to liver cancer cells, inducing apoptosis effectively. By combining NP treatment with histone deacetylase inhibitors, they achieved over 80% TRAIL-mediated cell death in target cancer cells. This approach offers a new potential strategy for cancer treatment by addressing multiple challenges associated with TRAIL therapy.

MOLECULAR THERAPY-ONCOLYTICS (2021)

Review Engineering, Biomedical

Toward Gene Transfer Nanoparticles as Therapeutics

Erin W. Kavanagh, Jordan J. Green

Summary: Genetic medicine has the potential to efficiently treat various human diseases, but the main challenge lies in the delivery of the treatment. Nanoparticles, engineered to mimic the efficiency of viruses, have shown promise in terms of safety, flexibility, targeting, and manufacturing. Recent progress in clinical validation of nonviral gene transfer nanoparticles has been significant, with FDA approval for gene expression and silencing. Lipid nanoparticles have been the focus, but other nanomaterials with desirable attributes like biodegradability, scalability, and cell targeting are also being developed. This review discusses the current state of the field, challenges in delivery, and opportunities for engineered nanomaterials, including long-term therapeutic gene editing.

ADVANCED HEALTHCARE MATERIALS (2022)

Article Multidisciplinary Sciences

High-throughput and high-content bioassay enables tuning of polyester nanoparticles for cellular uptake, endosomal escape, and systemic in vivo delivery of mRNA

Yuan Rui, David R. Wilson, Stephany Y. Tzeng, Hannah M. Yamagata, Deepti Sudhakar, Marranne Conge, Cynthia A. Berlinicke, Donald J. Zack, Anthony Tuesca, Jordan J. Green

Summary: Nanoparticle-based mRNA therapeutics show great promise, but cellular internalization and endosomal escape pose challenges for cytosolic delivery. Researchers developed a dual nanoparticle uptake and endosomal disruption assay, which can detect cellular internalization and endosomal disruption. The study found that this assay has higher predictive capacity for mRNA delivery compared to conventional polymer and nanoparticle characteristics.

SCIENCE ADVANCES (2022)

Article Materials Science, Multidisciplinary

Targeting strategies for mRNA delivery

Randall A. Meyer, Sarah Y. Neshat, Jordan J. Green, Jose Luis Santos, Anthony D. Tuesca

Summary: mRNA gene therapy has the potential to enable various therapeutic applications, but its successful clinical translation has been limited due to inadequate understanding of organ-specific protein expression. Studies have shown that carrier material properties and routes of administration are important factors in mRNA therapeutic expression profiles. Understanding trends in tissue-specific mRNA delivery materials can unlock the full potential of therapeutic mRNA medicines.

MATERIALS TODAY ADVANCES (2022)

Article Engineering, Biomedical

Machine learning guided structure function predictions enable in silico nanoparticle screening for polymeric gene delivery

Dennis Gong, Elana Ben-Akiva, Arshdeep Singh, Hannah Yamagata, Savannah Est-Witte, Julie K. Shade, Natalia A. Trayanova, Jordan J. Green

Summary: Developing efficient non-viral gene delivery reagents for hard-to-transfect cell types remains challenging, often relying on brute force screening. High-throughput computational methods for evaluating biomaterials can expedite optimization by quickly exploring large chemical design spaces. In this study, machine learning algorithms were applied to a dataset of synthetic biodegradable polymers, enabling the prediction of transfection efficiency. Experimental validation confirmed the accuracy of computational predictions, highlighting the potential of computational screening in the development of gene delivery nanoparticles.

ACTA BIOMATERIALIA (2022)

Article Nanoscience & Nanotechnology

Poly(Beta-Amino Ester)s as High-Yield Transfection Reagents for Recombinant Protein Production

Kathryn M. Luly, Huilin Yang, Stephen J. Lee, Wentao Wang, Seth D. Ludwig, Haley E. Tarbox, David R. Wilson, Jordan J. Green, Jamie B. Spangler

Summary: The study compared the use of PBAEs with linear 25 kDa PEI for transient transfection, showing that PBAEs demonstrated superior transfection efficiency and enhanced protein production in both HEK and CHO cells, making them potentially attractive reagents for recombinant protein production.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2022)

Review Nanoscience & Nanotechnology

Nonviral nanoparticle gene delivery into the CNS for neurological disorders and brain cancer applications

Joanna Yang, Kathryn M. Luly, Jordan J. Green

Summary: Nonviral nanoparticles offer an attractive alternative to viral vectors for gene therapy, encapsulating or functionalizing nucleic acids to protect them. Adjusting physiochemical properties of the nanoparticles can improve cellular uptake and gene delivery. Overcoming extracellular barriers, such as the blood-brain barrier, in gene therapy for the central nervous system is challenging but possible.

WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2023)

Article Multidisciplinary Sciences

Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination

Elana Ben-Akiva, Johan Karlsson, Shayan Hemmati, Hongzhe Yu, Stephany Y. Tzeng, Drew M. Pardoll, Jordan J. Green

Summary: Nanoparticle-based mRNA cancer vaccines show great promise for personalized cancer treatments. We developed a bioreducible lipophilic poly(beta-amino ester) nanocarrier that can efficiently deliver multiple antigen-encoding mRNAs and nucleic acid-based adjuvants to dendritic cells. The engineered nanocarrier facilitated targeted delivery without the need for surface functionalization and resulted in robust CD8+ T cell responses and efficient antitumor therapy in murine melanoma and colon adenocarcinoma models.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Materials Science, Biomaterials

Improvement of Islet Engrafts via Treg Induction Using Immunomodulating Polymeric Tolerogenic Microparticles

Sarah Y. Neshat, Stuart J. Bauer, Kelly R. Rhodes, Victor M. Quiroz, Valerie W. Wong, Shirley M. Lowmaster, Stephany Y. Tzeng, Jordan J. Green, Joshua C. Doloff

Summary: Type 1 diabetes (T1D) is a life-threatening condition that can be improved by islet transplantation, but the success can vary due to the patient's immune response. Artificial antigen-presenting cells (aAPCs) can promote immune acceptance and generate a tolerogenic response by inducing regulatory T cells (Tregs). The study investigated the properties of a specific type of aAPCs (TolAPCs) and their impact on the immune system in mice, showing potential for islet protection and glucose-stimulated insulin secretion. However, further improvements are needed for long-term efficacy and control of other immune cell responses.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2023)

Article Engineering, Biomedical

Polymeric nanoparticle gel for intracellular mRNA delivery and immunological reprogramming of tumors

Sarah Y. Neshat, Chun Hei Ryan Chan, Jawaun Harris, Osamah M. Zmily, Savannah Est-Witte, Johan Karlsson, Sydney R. Shannon, Manav Jain, Joshua C. Doloff, Jordan J. Green, Stephany Y. Tzeng

Summary: Immuno-oncology therapies aim to induce sustained tumor regression, but current methods are in need of improvement. An antigen-free method of cancer immunotherapy that stimulates the immune system without knowledge of neoantigens has been developed, along with a local delivery system to minimize systemic toxicity. A gene delivery nanoparticle platform has been engineered to reprogram the tumor microenvironment and activate cytotoxic lymphocytes, resulting in tumor regression and clearance.

BIOMATERIALS (2023)

Article Materials Science, Biomaterials

Biomaterial-Mediated Genetic Reprogramming of Merkel Cell Carcinoma and Melanoma Leads to Targeted Cancer Cell Killing In Vitro and In Vivo

Kathryn M. Luly, Jordan J. Green, Joel C. Sunshine, Stephany Y. Tzeng

Summary: In this study, researchers used reprogramming nanoparticles (NPs) to deliver immunostimulatory genes and enhance immunotherapy for skin cancer. They found that these NPs can reprogram the tumor immune microenvironment, induce strong T-cell-driven immune responses, and slow tumor growth and improve survival rates in vivo.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2023)

Review Materials Science, Biomaterials

Approaches towards biomaterial-mediated gene editing for cancer immunotherapy

Sydney R. Shannon, Elana Ben-Akiva, Jordan J. Green

Summary: Gene therapies are revolutionizing the treatment of many human diseases, and it is important to consider both the delivery materials and cargos for maximum efficacy and safety. Non-viral delivery mechanisms and CRISPR technology have great potential in immune cell gene editing, but there are challenges that need to be overcome.

BIOMATERIALS SCIENCE (2022)

Article Multidisciplinary Sciences

The endosomal pH regulator NHE9 is a driver of stemness in glioblastoma

Myungjun Ko, Monish R. Makena, Paula Schiapparelli, Paola Suarez-Meade, Allatah X. Mekile, Bachchu Lal, Hernando Lopez-Bertoni, Kristen L. Kozielski, Jordan J. Green, John Laterra, Alfredo Quinones-Hinojosa, Rajini Rao

Summary: Self-renewing stem cells play a crucial role in tumor initiation and therapeutic resistance in glioblastoma. The endosomal pH regulator NHE9 promotes cell surface expression and phosphorylation of multiple receptor tyrosine kinases (RTKs), leading to the activation of oncogenic signaling pathways and induction of pluripotency genes. Alkalization of the endosomal lumen through the use of chemical agents can bypass NHE9 and induce similar effects.

PNAS NEXUS (2022)

暂无数据